Clinical trial
Anti-Restenosis After AMI by Erythropoietin
NCT00423020 · Kyoto Prefectural University of Medicine, Other · Unknown status
Key facts
| NCT number | NCT00423020 |
|---|---|
| Title | Anti-Restenosis After AMI by Erythropoietin |
| Official title | Erythropoietin Prevention Trial of Coronary Restenosis and Cardiac Remodeling After Acute Myocardial Infarction (EPOC-AMI) |
| Lead sponsor | Kyoto Prefectural University of Medicine, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Erythropoietin |
| Enrollment | 72 |
| First posted | Jan 17, 2007 |
| Last update posted | Jan 17, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: